3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Management of Anabolic Steroid-Induced Infertility: Novel Strategies for Fertility Maintenance and Recovery

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          There is often inherent conflict in the overlapping fields of male fertility and andrology. While the goal of all male fertility specialists is to facilitate and preserve biologic paternity, many practitioners also care for a significant number of patients suffering from hypogonadism. Exogenous testosterone administration, the gold standard for the management of these patients, almost universally impairs spermatogenesis and can even completely eradicate it in some men. With steady increases in both the incidence of hypogonadism and average paternal age, practitioners are now encountering hypogonadal men who desire future fertility or men suffering the effects of earlier androgenic anabolic steroid use with increasing frequency. In this manuscript, we review management strategies for these complex patients and explore novel medications that may be of use in this population.

          Related collections

          Most cited references61

          • Record: found
          • Abstract: not found
          • Article: not found

          Evaluation and Management of Testosterone Deficiency: AUA Guideline

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Prevalence of hypogonadism in males aged at least 45 years: the HIM study

            The Hypogonadism in Males study estimated the prevalence of hypogonadism [total testosterone (TT) <300 ng/dl] in men aged ≥45 years visiting primary care practices in the United States. A blood sample was obtained between 8 am and noon and assayed for TT, free testosterone (FT) and bioavailable testosterone (BAT). Common symptoms of hypogonadism, comorbid conditions, demographics and reason for visit were recorded. Of 2162 patients, 836 were hypogonadal, with 80 receiving testosterone. Crude prevalence rate of hypogonadism was 38.7%. Similar trends were observed for FT and BAT. Among men not receiving testosterone, 756 (36.3%) were hypogonadal; odds ratios for having hypogonadism were significantly higher in men with hypertension (1.84), hyperlipidaemia (1.47), diabetes (2.09), obesity (2.38), prostate disease (1.29) and asthma or chronic obstructive pulmonary disease (1.40) than in men without these conditions. The prevalence of hypogonadism was 38.7% in men aged ≥45 years presenting to primary care offices.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Testosterone and Cardiovascular Disease.

              Testosterone (T) is the principal male sex hormone. As men age, T levels typically fall. Symptoms of low T include decreased libido, vasomotor instability, and decreased bone mineral density. Other symptoms may include depression, fatigue, erectile dysfunction, and reduced muscle strength/mass. Epidemiology studies show that low levels of T are associated with more atherosclerosis, coronary artery disease, and cardiovascular events. However, treating hypogonadism in the aging male has resulted in discrepant results in regard to its effect on cardiovascular events. Emerging studies suggest that T may have a future role in treating heart failure, angina, and myocardial ischemia. A large, prospective, long-term study of T replacement, with a primary endpoint of a composite of adverse cardiovascular events including myocardial infarction, stroke, and/or cardiovascular death, is needed. The Food and Drug Administration recently put additional restrictions on T replacement therapy labeling and called for additional studies to determine its cardiac safety.
                Bookmark

                Author and article information

                Journal
                World J Mens Health
                World J Mens Health
                WJMH
                The World Journal of Men's Health
                Korean Society for Sexual Medicine and Andrology
                2287-4208
                2287-4690
                April 2020
                26 March 2019
                : 38
                : 2
                : 141-150
                Affiliations
                [1 ]Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA.
                [2 ]Men's Health Center, Indianapolis, IN, USA.
                Author notes
                Correspondence to: Larry I. Lipshultz. Baylor College of Medicine, 6624 Fannin St, #1700, Houston, TX 77030, USA. Tel: +1-713-798-6270, Fax: +1-713-798-6007, larryl@ 123456bcm.edu
                Author information
                https://orcid.org/0000-0002-0525-3213
                https://orcid.org/0000-0001-8676-7285
                Article
                10.5534/wjmh.190002
                7076311
                30929329
                231c0a3c-0e76-4feb-8ec3-3b07bdd166ca
                Copyright © 2020 Korean Society for Sexual Medicine and Andrology

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 03 January 2019
                : 14 February 2019
                Categories
                Review Article
                Male Reproductive Health and Infertility

                anabolic steroids,clomiphene citrate,human chorionic gonadotropin,hypogonadism,infertility,testosterone

                Comments

                Comment on this article